# Robert A. Wolff

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-a-wolff/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,735 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 106 |
| i10-index | 345 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5035371911 |
| ORCID iD | https://orcid.org/0000-0002-6614-1610 |
| Works | 1,035 |

## Researcher papers

- [Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study](https://scholariq.org/papers/efficacy-of-rad001-everolimus-and-octreotide-lar-in-advanced-low-to-intermediate/)
- [Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas](https://scholariq.org/papers/fluorouracil-doxorubicin-and-streptozocin-in-the-treatment-of-patients-with/)
- [Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance](https://scholariq.org/papers/phase-ii-trial-of-infusional-fluorouracil-irinotecan-and-bevacizumab-for/)
- [Pancreatic Adenocarcinoma, Version 2.2014](https://scholariq.org/papers/pancreatic-adenocarcinoma-version-2-2014/)
- [Pancreatic Adenocarcinoma, Version 2.2012](https://scholariq.org/papers/pancreatic-adenocarcinoma-version-2-2012/)
- [Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.](https://scholariq.org/papers/rapid-fractionation-preoperative-chemoradiation-pancreaticoduodenectomy-and/)
- [PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors](https://scholariq.org/papers/pik3ca-pten-mutations-and-akt-activation-as-markers-of-sensitivity-to-allosteric/)
- [Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/<i>neu</i>](https://scholariq.org/papers/herceptin-and-gemcitabine-for-metastatic-pancreatic-cancers-that-overexpress-her/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Colorectal Cancer Screening and Detection](https://scholariq.org/topics/colorectal-cancer-screening-and-detection/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.